BEAM
BEAM
NASDAQ · Biotechnology

Beam Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$34.14
+1.66 (+5.11%)
As of Jun 21, 9:59 PM ET ·
Analyst Consensus
Strong Buy
25
Analysts
High
Coverage
Buy 22 88%
Hold 3 12%
Sell 0 0%
Price Target
Analyst Price Target +81.8% upside
Low Target $37.88
Average Target $62.07
High Target $80.69
Current Price $34.14
Current
$34.14
Target
$62.07
$37.88 $62.07 avg $80.69
Scenario Analysis
Bear Case
$37.88
11.0%
Low target
Base Case
$62.07
+81.8%
Avg target
Bull Case
$80.69
+136.4%
High target
Risk/Reward
12.4x
Highly favorable
Price in Context
52-Week High
$36.44
-6.3% from high
52-Week Low
$15.60
+118.8% from low
50-Day SMA
$28.48
+19.9% vs SMA
200-Day SMA
$22.69
+50.5% vs SMA
RSI (14)
44.0
Neutral
Target vs 52W High
$62.07
+70.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -39.1%